Tranexamic acid is an antifibrinolytic agent. It does not promote clot formation but prevents the breakdown of clots that have already formed. It works by competitively inhibiting the activation of plasminogen to plasmin. Plasmin is the main enzyme of the fibrinolytic system that breaks down fibrin clots. By blocking plasmin formation, tranexamic acid stabilizes clots and reduces bleeding. It is particularly useful in conditions where there is excessive fibrinolysis, such as after major surgery (especially cardiac or orthopedic), trauma, menorrhagia (heavy menstrual bleeding), and in some inherited bleeding disorders like von Willebrand disease. It is also used as a mouthwash to control bleeding in dental procedures for patients on anticoagulants.

Break down complex topics into smaller, manageable chunks for easier recall.

Zambia

• Naomi Miselo – 31 pts

• Visual Pathway Lesions
• Positive and Negative Symptoms
• Hallucinations and Delusions
• Antipsychotic Medications
• Emergency: Environmental Emergencies